HealthQuill cystectomy
Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.
Drugs Research

AstraZeneca’s blood cancer combination drug shows positive results in end trial

HQ Team May 13, 2025: AstraZeneca’s POTOMAC Phase III trial has demonstrated that combining Imfinzi (durvalumab) with standard Bacillus Calmette-Guérin (BCG) therapy significantly improves disease-free survival (DFS) in patients.

Read More